Highly Aware Population to Favor Dental Biomaterials Market Growth

Market Dynamics:
Market Research Future (MRFR) says that the global Dental Biomaterials Market could achieve a CAGR of 6.2% during the forecast period (2018-2023).
Growth Boosters and Top Challenges:
The World Health Organization (WHO) says that oral diseases as one of the most expensive diseases prevalent, not only in developing countries but also in the developed ones. The OECD 2013 analysis concludes that the treatment of oral diseases such as dental biomaterials accounted for 5% of the total health expenditure in economically stable countries. Dental biomaterials are advanced products within preventive and restorative dentistry that have a high success rate in oral treatment as well as prevention. This favorable aspect of these products is bound to create demand for the global dental biomaterials market in the subsequent years.
The quickly increasing number of qualified dental professionals could elevate access to dental care. Recent statistics released by the Brazilian Institute of Geography and Statistics (IBGE) states that the country has about 174,000 dentists, which translates to 11% of the total number in the world. Following the implementation of the Oral Health National Policy in Brazil since 2004, there has been a rise in population that is more aware of oral health.
Prominent Companies
·         Dentsply Sirona
·         Geistlich Pharma AG
·         Zimmer Biomet Holdings
·         3M Company
·         Straumann Holding AG
·         Carpenter Technology Corporation
·         Kuraray Co
·         Medtronic PLC
·         Henry Schein
·         GC Corporation
·         Royal DSM
Market Segmentation:
·         The global dental biomaterials market has been segmented on the basis of type, application, and end-user.
·         Type-based segments covered by the report are ceramic biomaterials, metallic biomaterials, metal-ceramic biomaterials, polymeric biomaterials, and natural biomaterials. The metallic biomaterials segment has been split into stainless steel, chromium alloys and titanium, and others.
·         Applications of dental biomaterials are prosthodontics, implantology, orthodontics, and others.
·         The end-user segment consists of dental laboratories, dental product manufacturers, dental academies, research institutes, and dental hospitals and clinics.
Regional Outlook
Asia Pacific, Middle East & Africa, the Americas and Europe are the main markets for dental biomaterials.
The Americas controls the major portion of the global dental biomaterials market. The growing prevalence of caries, combined with the presence of renowned players in the region leaves a positive impact on the market. On top of that, high dental expenditure boosts the regional market. An article by the American College of Prosthodontists divulged that roughly over 36 million Americans are missing teeth and around 120 million are missing at least one tooth. These conditions in the region help raising the demand for prosthodontics and implants, which elevates the market position.
Europe is the second-most profitable market for dental biomaterials market. Europe market is divided into Eastern Europe and Western Europe. Western Europe, with a bigger share of the market, benefits from the presence of highly developed countries and a rising number of dental procedures. Other than this, massive government funding in the field helps with market growth. In 2018, Oral Health Foundation had reported that nearly 60% of adults in Northern Ireland and 61% of adults in England visited NHS dentists on a regular basis. These numbers clearly indicate the positive market scope for the future

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more